Search Results 111-120 of 17064 for EBV

1. Radiation Clinical Trials - Mayo Clinic Research

   There are two study questions we are asking in this randomized phase II/III trial based on a blood biomarker, Epstein Barr virus (EBV) deoxyribonucleic acid ( ...

2. Leukoplakia - Diagnosis and treatment - Mayo Clinic

   These medicines can keep the Epstein-Barr virus, the cause of hairy leukoplakia, under control. Treatment that is put directly on the patch also may be used ...

3. Study Of AZD5863 In Adult Participants With Advanced Or Metastatic Solid Tumors - Mayo Clinic

   ... EBV, uncontrolled active systemic fungal, bacterial or other infection * Cardiac conditions as defined by the protocol * History of thromboembolic event ...

4. A Phase 1-2 Multi-Center Study Evaluating Axicabtagene Ciloleucel in Subjects With Refractory Aggressive Non-Hodgkin Lymphoma (ZUMA-1) - Mayo Clinic

   DLBCL not otherwise specified; T cell/histiocyte rich large B cell lymphoma; DLBCL associated with chronic inflammation; Epstein-Barr virus (EBV)+ DLBCL of the ...

5. Fecal Microbiota Transplantation for C. Difficile Infection in Solid Organ Transplant Recipients - Mayo Clinic

   History of positive IgG testing to cytomegalovirus (CMV) and Epstein Barr Virus (EBV) for subject. Clinical response to 4-10 days of C. difficile treatment ...

6. Mosunetuzumab-axgb (subcutaneous route) - Side effects & uses - Mayo Clinic

   Make sure you tell your doctor if you have any other medical problems, especially: Serious infection (eg, Epstein-Barr virus), history of—Use with caution. May ...

7. A Study Evaluating the Effectiveness of Axicabtagene Ciloleucel Compared to Standard of Care Therapy in Subjects with Relapsed/Refractory Diffuse Large B Cell Lymphoma - Mayo Clinic

   Epstein-Barr virus (EBV) + DLBCL. Relapsed or refractory disease after first-line chemoimmunotherapy: Refractory disease defined as no complete remission to ...

8. A Global Study to Assess the Effects of Durvalumab + Domvanalimab Following Concurrent Chemoradiation in Participants With Stage III Unresectable NSCLC - Mayo Clinic

   Active EBV infection, or known or suspected chronic active EBV infection at screening. Current or prior use of immunosuppressive medication within 14 days ...

9. Immune Response to Pneumococcal Polysaccharide Vaccine (23-valent) Predicts Asthma Status and Outcomes in Late Adolescents With Asthma - Mayo Clinic

   ... EBV), other chronic diseases (multiple sclerosis, etc), renal disease such nephritic syndrome, and protein losing enteropathy; Current or previous use ...

10. Publications - Rumeal D. Whaley, M.D. - Mayo Clinic

    Epstein-Barr Virus-Associated Smooth Muscle Tumors of Larynx: A ... Lymphoepithelial Carcinoma of Salivary Gland EBV-association in Endemic ...